Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07587229 · ClinicalTrials.gov registry record
Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
A clinical trial, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- 329
- Enrollment target
NCT07587229 is a clinical trial that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 329 participants.
The verdict
NCT07587229 is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- 329 participants
- Enrollment target
Study Summary
This study aims to develop a model to predict response to chemotherapy in gastric cancer using RNA splicing information from tumor tissue. By analyzing genetic patterns and applying machine learning, the study seeks to identify patients who are less likely to benefit from treatment, helping guide clinical decision-making.
Interventions
- OTHER Observational study (no intervention)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2027-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07587229
The ClinicalTrials.gov registry entry for NCT07587229 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational study (no intervention) is the first listed.
NCT07587229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07587229 about?
NCT07587229 is a clinical study titled "Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer". This study aims to develop a model to predict response to chemotherapy in gastric cancer using RNA splicing information from tumor tissue. By analyzing genetic patterns and applying machine learning, the study seeks to identify patients who are less likely to benefit from treatment, helping guide c...
What is the current status of trial NCT07587229?
This trial is currently recruiting. The enrollment target is 329 participants. The study started on 2026-05-01. Estimated completion is 2027-01-01.
What interventions are being tested in trial NCT07587229?
The interventions under investigation include: Observational study (no intervention) (OTHER).
Who is sponsoring clinical trial NCT07587229?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.